<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38359962</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children".</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2301761</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.01761-2023</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic substantially impacted different age groups, with children and young people not exempted. Many have experienced enduring health consequences. Presently, there is no consensus on the health outcomes to assess in children and young people with post-COVID-19 condition. Furthermore, it is unclear which measurement instruments are appropriate for use in research and clinical management of children and young people with post-COVID-19. To address these unmet needs, we conducted a consensus study, aiming to develop a core outcome set (COS) and an associated core outcome measurement set (COMS) for evaluating post-COVID-19 condition in children and young people. Our methodology comprised of two phases. In phase 1 (to create a COS), we performed an extensive literature review and categorisation of outcomes, and prioritised those outcomes in a two-round online modified Delphi process followed by a consensus meeting. In phase 2 (to create the COMS), we performed another modified Delphi consensus process to evaluate measurement instruments for previously defined core outcomes from phase 1, followed by an online consensus workshop to finalise recommendations regarding the most appropriate instruments for each core outcome. In phase 1, 214 participants from 37 countries participated, with 154 (72%) contributing to both Delphi rounds. The subsequent online consensus meeting resulted in a final COS which encompassed seven critical outcomes: fatigue; post-exertion symptoms; work/occupational and study changes; as well as functional changes, symptoms, and conditions relating to cardiovascular, neuro-cognitive, gastrointestinal and physical outcomes. In phase 2, 11 international experts were involved in a modified Delphi process, selecting measurement instruments for a subsequent online consensus workshop where 30 voting participants discussed and independently scored the selected instruments. As a result of this consensus process, four instruments met <i>a priori</i> consensus criteria for inclusion: PedsQL multidimensional fatigue scale for "fatigue"; PedsQL gastrointestinal symptom scales for "gastrointestinal"; PedsQL cognitive functioning scale for "neurocognitive" and EQ-5D for "physical functioning". Despite proposing outcome measurement instruments for the remaining three core outcomes ("cardiovascular", "post-exertional malaise", "work/occupational and study changes"), a consensus was not achieved. Our international, consensus-based initiative presents a robust framework for evaluating post-COVID-19 condition in children and young people in research and clinical practice <i>via</i> a rigorously defined COS and associated COMS. It will aid in the uniform measurement and reporting of relevant health outcomes worldwide.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Seylanova</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Independent researcher, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Authors contributed equally to the study; apart from the two joint first authors, who contributed equally, the primary study team members and the last author, authors are listed in alphabetical order.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chernyavskaya</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Rheumatology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Medical Research Center for Children's Health, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Authors contributed equally to the study; apart from the two joint first authors, who contributed equally, the primary study team members and the last author, authors are listed in alphabetical order.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degtyareva</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mursalova</LastName><ForeName>Aigun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajam</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aktulaeva</LastName><ForeName>Khazhar</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roshchin</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9377-1394</Identifier><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobkova</LastName><ForeName>Polina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiyegbusi</LastName><ForeName>Olalekan Lee</ForeName><Initials>OL</Initials><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anbu</LastName><ForeName>Anbarasu Theodore</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Alder Hey Children's NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfelbacher</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asadi-Pooya</LastName><ForeName>Ali Akbar</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashkenazi-Hoffnung</LastName><ForeName>Liat</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brackel</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Paediatric Pulmonology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Tergooi Hospital, Blaricum, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8567-2639</Identifier><AffiliationInfo><Affiliation>Center for Global Health Research and Studies, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groote</LastName><ForeName>Wouter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Janet V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department for Women's and Children's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dona</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7105-2105</Identifier><AffiliationInfo><Affiliation>Department for Women's and Children's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn Galvin</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Cork, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genuneit</LastName><ForeName>Jon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5764-1528</Identifier><AffiliationInfo><Affiliation>Pediatric Epidemiology, Department of Pediatrics, Medical Faculty, Leipzig University, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goss</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Long Covid Kids Charity, Salisbury, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Christina J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0003-3672-6631</Identifier><AffiliationInfo><Affiliation>School of Psychology, University of Surrey, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuppalli</LastName><ForeName>Krutika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department for Women's and Children's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malone</LastName><ForeName>Laura A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Kennedy Krieger Institute, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Neurology and Physical Medicine and Rehabilitation, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McFarland</LastName><ForeName>Sammie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Needham</LastName><ForeName>Dale M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Outcomes After Critical Illness and Surgery (OACIS) Research Group, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nekliudov</LastName><ForeName>Nikita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Timothy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Carlos R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Yale University School of Medicine, Department of Pediatrics, Section of Infectious Diseases, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale University School of Public Health, Department of Biostatistics, Division of Health Informatics, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale New Haven Children's Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiess</LastName><ForeName>Nicoline</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brain Health Unit, Mental Health and Substance Use Department, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segal</LastName><ForeName>Terry Y</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2764-1177</Identifier><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorne</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Population, Policy and Practice Research and Teaching Dept, University College London GOS Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijverberg</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4579-4081</Identifier><AffiliationInfo><Affiliation>Amsterdam University Medical Centers, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>John O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Were</LastName><ForeName>Wilson Milton</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Department for Women's and Children's Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Paula R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>MRC-NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9652-6856</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia daniel.munblit@kcl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Care in Long Term Conditions, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research and Clinical Center for Neuropsychiatry, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Authors contributed equally to the study; apart from the two joint first authors, who contributed equally, the primary study team members and the last author, authors are listed in alphabetical order.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PC-COS Children Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>K23 AI159518</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: D. Munblit is a Co-Chair of International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Global Paediatric Long COVID Working Group, member of ISARIC working group on long-term follow-up in adults. C. Apfelbacher reports grants or contracts from Dr Wolff Group, Bionorica and The European Cooperation in Science and Technology (COST); he also acknowledges consulting fees from the Dr Wolff Group, Bionorica, Sanofi and LEO Pharma; he serves as a Co-Chair Harmonising Outcome Measures for Eczema (HOME) initiative and is Co-Chair of the Hand Eczema Core Outcome Set (HECOS) initiative and is core principal investigator of the KUNOKids Health Study (Regensburg, Germany). J.V. Diaz is the lead of the clinical management response pillar for COVID-19 and in that capacity convenes the WHO Clinical Characterization and Management Research working group; the Post COVID-19 COS steering committee was a sub-working group of this bigger group. O.L. Aiyegbusi has received research grants from UCB, Kidney Research UK, Gilead Sciences Ltd, The Health Foundation, NIHR Birmingham BRC, NIHR ARC, NIHR BTRU, Innovate UK, Merck, GSK, Anthony Nolan and Sarcoma UK; he has also received personal fees from GSK, Gilead Sciences, Innovate UK and Merck. C.R. Oliveira receives grant support from the National Institutes of Health (NIH), grant numbers OT2HL161847 and K23AI159518. P.R. Williamson is chair of the Core Outcome Measures in Effectiveness Trials (COMET) Management Group. Other authors declare that they have no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Kassim</LastName><ForeName>Asiah</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chevinsky</LastName><ForeName>Jennifer R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choong</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duncan</LastName><ForeName>Rae</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esposito</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foster</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guekht</LastName><ForeName>Alla</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaure</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>Carrie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matthies-Bonn</LastName><ForeName>Vivienne</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matvienko-Sikar</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCloud</LastName><ForeName>Lorraine</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McParland</LastName><ForeName>Donna C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miron</LastName><ForeName>Victor Daniel</ForeName><Initials>VD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murthy</LastName><ForeName>Srinivas</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connel</LastName><ForeName>Sarah O</ForeName><Initials>SO</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ogonowska-Slodownik</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pavare</LastName><ForeName>Jana</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robertson</LastName><ForeName>Paula</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossman</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#x103;ndulescu</LastName><ForeName>Oana</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm Calum G</ForeName><Initials>MCG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snipaitiene</LastName><ForeName>Ausra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xf8;raas</LastName><ForeName>Arne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tulen</LastName><ForeName>Lola</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galaz</LastName><ForeName>Gonzalo Valenzuela</ForeName><Initials>GV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vickers</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vilser</LastName><ForeName>Daniel Christian</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waak</LastName><ForeName>Michaela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wells</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winer</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asmanov</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Comberiati</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>16</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>15</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38359962</ArticleId><ArticleId IdType="pmc">PMC10938351</ArticleId><ArticleId IdType="doi">10.1183/13993003.01761-2023</ArticleId><ArticleId IdType="pii">13993003.01761-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Munblit D, O'Hara ME, Akrami A, et al. . Long COVID: aiming for a consensus. Lancet Respir Med 2022; 10: 632&#x2013;634. 10.1016/S2213-2600(22)00135-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00135-7</ArticleId><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al. . Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep 2022; 12: 9950. doi:10.1038/s41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J 2021; 40: e482&#x2013;e487. doi:10.1097/INF.0000000000003328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators , Wulf Hanson S, Abbafati C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604&#x2013;1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea M, Pawelek P, Ayoubkhani D. Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK. 2023. www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023#prevalence-of-ongoing-symptoms-following-coronavirus-infection-in-the-uk-data. Date last accessed: 17 September 2023. Date last updated: 30 March 2023.</Citation></Reference><Reference><Citation>Trapani G, Verlato G, Bertino E, et al. . Long COVID-19 in children: an Italian cohort study. Ital J Pediatr 2022; 48: 83. doi:10.1186/s13052-022-01282-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-022-01282-x</ArticleId><ArticleId IdType="pmc">PMC9163526</ArticleId><ArticleId IdType="pubmed">35659358</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Buonsenso D, Sigfrid L, et al. . Post-COVID-19 condition in children: a COS is urgently needed. Lancet Respir Med 2022; 10: 628&#x2013;629. doi:10.1016/S2213-2600(22)00211-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00211-9</ArticleId><ArticleId IdType="pmc">PMC9197248</ArticleId><ArticleId IdType="pubmed">35714657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkham JJ, Williamson P. Core outcome sets in medical research. BMJ Med 2022; 1: e000284. doi:10.1136/bmjmed-2022-000284</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000284</ArticleId><ArticleId IdType="pmc">PMC9951367</ArticleId><ArticleId IdType="pubmed">36936568</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson PR, Altman DG, Bagley H, et al. . The COMET Handbook: version 1.0. Trials 2017; 18: Suppl. 3, 280. doi:10.1186/s13063-017-1978-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-017-1978-4</ArticleId><ArticleId IdType="pmc">PMC5499094</ArticleId><ArticleId IdType="pubmed">28681707</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, et al. . A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med 2022; 10: 715&#x2013;724. doi:10.1016/S2213-2600(22)00169-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorst S, Seylanova N, Harman N, et al. . 
A Core Outcome Measurement Set (COMS) for Research and Clinical Practice in Post COVID-19 Condition (Long COVID) in Adults: an International Delphi Consensus Study. 2023. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4317875. Date last accessed: 17 September 2023.</Citation></Reference><Reference><Citation>Dodd S, Clarke M, Becker L, et al. . A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. J Clin Epidemiol 2018; 96: 84&#x2013;92. doi:10.1016/j.jclinepi.2017.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2017.12.020</ArticleId><ArticleId IdType="pmc">PMC5854263</ArticleId><ArticleId IdType="pubmed">29288712</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. . GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395&#x2013;400. doi:10.1016/j.jclinepi.2010.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.09.012</ArticleId><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) . A Clinical Case Definition for Post COVID-19 Condition in Children and Adolescents by Expert Consensus. 2023. www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1. Date last accessed: 20 September 2023. Date last updated: 16 February 2023.</Citation></Reference><Reference><Citation>Verstraete J, Scott D. Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents. J Patient Rep Outcomes 2022; 6: 67. doi:10.1186/s41687-022-00480-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-022-00480-9</ArticleId><ArticleId IdType="pmc">PMC9203648</ArticleId><ArticleId IdType="pubmed">35708825</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin N, Pan T, Kreimeier S, et al. . Valuing EQ-5D-Y: the current state of play. Health Qual Life Outcomes 2022; 20: 105. doi:10.1186/s12955-022-01998-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-01998-8</ArticleId><ArticleId IdType="pmc">PMC9260978</ArticleId><ArticleId IdType="pubmed">35794607</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorst SL, Prinsen CAC, Salcher-Konrad M, et al. . Methods used in the selection of instruments for outcomes included in core outcome sets have improved since the publication of the COSMIN/COMET guideline. J Clin Epidemiol 2020; 125: 64&#x2013;75. doi:10.1016/j.jclinepi.2020.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.05.021</ArticleId><ArticleId IdType="pubmed">32470621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen RA, Henley AC, Brouwer ES, et al. . Geographic Information System mapping as a tool to assess nonresponse bias in survey research. Res Social Adm Pharm 2007; 3: 249&#x2013;264. doi:10.1016/j.sapharm.2006.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2006.10.001</ArticleId><ArticleId IdType="pubmed">17945157</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith W. Does Gender Influence Online Survey Participation? A Record-Linkage Analysis of University Faculty Online Survey Response Behavior. 2008. https://files.eric.ed.gov/fulltext/ED501717.pdf. Date last accessed: 17 September 2023.</Citation></Reference><Reference><Citation>Jassat W, Reyes LF, Munblit D, et al. . Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet 2023: 402: 1115&#x2013;1117. doi:10.1016/S0140-6736(23)01685-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01685-9</ArticleId><ArticleId IdType="pubmed">37652071</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>